EPIWORLD (ASX: 02726) has announced the results of its board and supervisory committee elections following its Annual General Meeting.

Shareholders approved several appointments to the company's second-term board of directors. Dr. Jianhui Zhao and Ms. Menghan Pan were appointed as executive directors. Ms. Jieping Xie and Ms. Danxia Guo were appointed as non-executive directors. Dr. Junyong Kang, Dr. Yi Liao, and Dr. Xinlong Su were appointed as independent non-executive directors.

The term for all second-term board directors commenced on June 22, 2026, and will last for three years. They are eligible for re-election upon the expiry of their terms.

Due to the board transition, Ms. Liting Bai has stepped down as an executive director, while Mr. Wei Fang and Mr. Ping Su have stepped down as non-executive directors. These changes took effect on June 22, 2026.

At the same meeting, shareholders approved the appointment of Ms. Yu Ni and Mr. Weining Qian as shareholder representative supervisors for the second-term supervisory committee. Mr. Kaixi Li was elected by the company's staff congress as the employee representative supervisor, completing the formation of the second-term supervisory committee.

The term for all second-term supervisors also began on June 22, 2026, and will last for three years, with eligibility for re-election.

Consequently, Mr. Guoyi Wu has stepped down as a shareholder representative supervisor, effective June 22, 2026.

The board is pleased to announce that Dr. Jianhui Zhao has been elected as Chairman of the Board. His term as Chairman is concurrent with the term of the second-term board of directors.